Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Dermatology/Plastic Surgery
Disease Category: Rosacea
Trial Information
An exploratory, multi-center, investigator-blinded, active-controlled study to investigate the efficacy of topical azelaic acid (AzA) 15% gel twice daily or metronidazole topical gel 1% once daily, plus anti-inflammatory dose doxycycline (40 mg) once daily in subjects with moderate papulopustular rosacea
Do you have Rosacea?
You may be eligible to participate in a research study of an FDA approved gel and oral medication
-18 years of age or older
- Have acne-like bumps on your face
-7 visits with a dermatologist
-Up to $350 in compensation
For more information, please email harvardskinstudies@partners.org or call (617)726-5066
Lynne Hermosilla
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Phone: 617-726-5066
EMail: harvardskinstudies@partners.org
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
